20523 ⎘
Medicinal preparations containing organic active ingredients; Carbohydrates; Sugars; Derivatives thereof; Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
Pesticidal ear tag
#3002Synthetic mechanical hemostatic composition, method of making and use thereof
#3003Method of treating neurological conditions with oleandrin
#3004Methods for improved wound closure employing olivamine and human umbilical vein endothelial cells
#3005Compositions and method for improving endothelial function and cardiovascular health
#3006Crystalline forms of a macrolide, and uses therefor
#300718-Membered Macrocycles and Analogs Thereof
#3008Antibiotic macrocycle compounds and methods of manufacture and use thereof
#3009COMPOSITIONS COMPRISING FLAVONOID-CONTAINING EXTRACTS FROM PLANTS OF THE GENUS CITRUS AND/OR ISOLATED CITRUS FLAVONOIDS AND SPECIFIC CATIONIC SURFACE ACTIVE AGENTS, AND SAID COMPOSITION FOR USE AS AN AGENT FOR TREATING INFESTATIONS WITH HEAD LICE
#3010Pharmaceutical composition, methods for treating and uses thereof
#3011Topical treatment of radiation dermatitis using hamelia patens
#3012Use of a polyphenol for the treatment of a cancerous or pre-cancerous lesion of the skin
#3013Compounds for enhancing arginase activity and methods of using same
#3014Abnormal intraocular pressure treatment
#3015Treatment for Alzheimer's Disease
#3016Composition containing styraxlignolide A or the aglycone thereof as an active ingredient for preventing or treating asthma
#3017Compositions and methods of delivery of pharmacological agents
#3018STANDARDIZED PLANT EXTRACT, PROCESS FOR OBTAINING THE SAME AND USES THEREOF
#3019NOVEL ANTIBACTERIAL COMPOUNDS, METHODS OF MAKING THEM, AND USES THEREOF
#3020Methods and compositions for treating inflammatory bowel disease
#3021Pharmaceutical composition and uses thereof
#3022COMPOSITION AND METHODS TO ENHANCE ANTI-OXIDATION, GUT FLORA AND IMMUNITY IN PETS
#3023Combination Of An Aminoacyl-tRNA Synthetase Inhibitor With A Further Antibacterial Agent For Attenuating Multiple Drug Resistance
#3024Therapeutic Compounds
#3025METHOD FOR ISOLATING SMALL MOLECULES WITH IMPORTANT BIOLOGICAL ACTIVITY USING YEAST
#3026SILICON NANOCARRIER FOR DELIVERY OF DRUG, PESTICIDES AND HERBICIDES , AND FOR WASTE WATER TREATMENT
#3027Environmental Clostridial Bacteriotherapy and Related Formulations and Methods of Manufacture and Use
#3028Compositions for treating infection
#3029METHODS FOR INHIBITING INSECT INFESTATIONS
#3030METHOD FOR PRODUCING AN ENRICHED EXTRACT FROM VITIS VINIFERA L. LEAVES
#3031METHODS OF TREATING MUSCULAR DYSTROPHIES
#3032THERAPEUTIC COMBINATION FOR THE TREATMENT OF CANCER
#3033PROCESS FOR INHIBITION OF CEREBRAL DAMAGE ASSOCIATED WITH ISCHEMIA BY ANTHOCYANINS AND ANTHOCYANIDINS
#3034Topical application of ivermectin for the treatment of dermatological conditions/afflictions
#3035Glycoside derivatives and uses thereof
#3036Cyclodextrin-based polymers for therapeutics delivery
#3037Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof
#3038PDE III inhibitors for treatment of asymptomatic heart failure
#3039SUGAR PLANT DERIVED BY-PRODUCTS AND METHODS OF PRODUCTION THEREOF
#3040COMBINATION COMPRISING CNDAC (2'-CYANO-2'-DEOXY-N4-PALMITOYL-1-BETA-D-ARABINOFURANOSYL-CYTOSINE) AND A CYTOTOXIC AGENT
#3041AGE PRODUCTION INHIBITOR
#3042COMBINATION THERAPY INCLUDING ISOPHOSPHORAMIDE MUSTARD, ANALOGS, OR SALTS THEREOF
#3043Water-soluble pharmaceutical composition comprising at least one therapeutically active substance having hydrophobic properties and at least one compound selected from among sialoglycosphingolipids, glycosphingolipids or a mixture of sialoglycosphingolipids and glycosphingolipids
#3044Multiple sign bit hiding within a transform unit
#3045Muscadine compositions with anti-oxidant activity
#3046Targeted osmotic lysis of cancer cells
#3047Novel IDO Inhibitors and Methods of Use Thereof
#3048Methods for treating multiple myeloma using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione in combination with proteasome inhibitor
#3049Compositions and methods for the treatment of progressive multifocal leukoencephalopathy (PML)
#3050Otic formulations, methods and devices
#3051Method of treating otitis externa using macrocyclic lactone compound
#3052Method of treating hemorrhoids using macrocyclic lactone compound
#3053Compositions for controlling heartworm infestation
#3054Growth inhibitory effects of nanoparticles containing triterpene glycosides or triterpenes
#3055Hydrous crystalline 2-O-α-D-glucosyl-L-ascorbic acid, particulate composition comprising the same, their preparation and uses
#3056Method of treating herpes virus infection using macrocyclic lactone compound
#3057Compositions for treating heartworm infestation
#3058Micelle encapsulation of a combination of therapeutic agents
#3059Compositions including anthocyanin or anthocyanidin for the prevention or treatment of articular cartilage-associated conditions
#3060CANCER THERAPY USING A COMBINATION OF A HSP90 INHIBITORY COMPOUND AND A TOPOISOMERASE II INHIBITOR
#3061Composition and method for compounded therapy
#3062Composition and method for compounded therapy
#3063Apple Skin Extracts for Treating Cardiovascular Disease
#3064ANTIMICROBIAL COMPOUNDS
#3065Telodendrimer nanodiscs without apolipoprotein
#3066Use of icariin and epimedium flavonoids containing icariin to treat diseases associated with myelin sheath lesion
#3067Phytonutrient compositions and methods to protect against radical mediated cellular and DNA damage
#3068Method of preventing early infections
#3069METHODS FOR INHIBITION OF CELL PROLIFERATION, SYNERGISTIC TRANSCRIPTION MODULES AND USES THEREOF
#3070NEUTRALIZATION OF FLT3 LIGAND AS A LEUKEMIA THERAPY
#3071Substituted triazolopyridines
#3072Levocarrimycin, pharmaceutical compositions, preparation methods and uses thereof
#3073Anti-Protozoal for Apicomplexan Protozoa
#3074Compositions and methods for treatment of cancer
#3075Topical Combination Formulations of Macrocyclic Lactones with Synthetic Pyrethroids
#3076Methods of treatment using combination therapy
#3077EPIGENETIC MECHANISMS OF ANTI-FIBROTIC ACTION FOR THE LIVER
#3078METHODS OF TREATMENT, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
#3079Composition comprising ligustroflavone, rhoifolin and hyperin and its pharmaceutical application
#3080METHOD OF DETERMINING ACUTE MYELOID LEUKEMIA RESPONSE TO TREATMENT WITH FARNESYLTRANSFERASE INHIBITORS
#3081Analogues of etoposide for the treatment of tumours
#3082Methods of inhibition of protein fucosylation in vivo using fucose analogs
#3083Antifungal and antiparasitic polyene macrolides
#3084Methods and compositions for inhibiting the nuclear factor κB pathway
#3085Ratiometric Combinatorial Drug Delivery
#3086Composition containing iridoids and uses thereof
#3087Compounds useful as inhibitors of ATR kinase
#3088Compounds useful as inhibitors of ATR kinase
#3089Compounds useful as inhibitors of ATR kinase
#3090Compounds useful as inhibitors of ATR kinase
#3091COATING OF PARTICLES COMPRISING A PHARMACEUTICALLY ACTIVE INGREDIENT WITH A CARBONATE SALT OR PHOSPHATE SALT
#3092ANTI-INFLAMMATORY COMPOSITIONS FOR TREATING NEURO-INFLAMMATION
#3093Anti-aging formulations
#3094Administration of avermectin/milbemycin compounds for the treatment of ophthalmic pathologies
#3095USE OF FLAVONOIDE COMPOUNDS FOR THE PROPHYLAXIS AND THERAPY OF ISCHAEMIC OR INFLAMMATORY HEART AND CARDIOVASCULAR DISEASES
#3096Composition for treating or preventing neurodegenerative brain diseases comprising black bean extract
#3097Compositions comprising at least one aqueous phase and at least one fatty phase which comprises avermectin compounds
#3098ANTIBIOTIC COMPOSITIONS
#3099VEGF production promoter
#3100Methods and materials for reducing the risk of infections
#3101PHARMACEUTICAL COMPOSITION COMPRISING A SGLT2 INHIBITOR IN COMBINATION WITH A DPP-IV INHIBITOR
#3102COMPOSITION FOR PREVENTION, AMELIORATION OR TREATMENT OF METABOLIC SYNDROME
#3103Aminopyrazines as ATR kinase inhibitors
#3104Hyaluronic acid decomposition-promoting factor and inhibitor thereof
#3105Method for treating thrombotic disorders using quercetin-containing compositions
#3106AVERMECTIN/METRONIDAZOLE COMPOSITIONS FOR TREATING AFFLICTIONS OF THE SKIN, E.G., ROSACEA
#3107INJECTABLE FORMULATION OF A MACROCYCLIC LACTONE AND LEVAMISOLE
#3108Methods of accelerating muscle growth, decreasing fat deposits and improving feed efficiency in livestock animals
#3109Manufacturing method for polyphenol composition
#3110Method for treating varicocele or male infertility using anthocyanin extracted from black soybean
#3111INDIBULIN THERAPY
#3112Combinatorial therapies for the treatment of neoplasias using the opioid growth factor receptor
#3113Treatment of prolonged status epilepticus
#3114EXTRACTS AND ISOLATED FLAVONOIDS FROM EUPHORBIA CUNEATA USEFUL AS ANTI-ULCER AGENTS
#3115NOVEL HIV REVERSE TRANSCRIPTASE INHIBITORS
#3116PKC ACTIVATION AS A MEANS FOR ENHANCING sAPPalpha SECRETION AND IMROVING COGNITION USING BRYOSTATIN TYPE COMPOUNDS
#3117Parasiticidal compositions comprising an isoxazoline active agent, methods and uses thereof
#3118Phenolic compositions derived from apple skin and uses thereof
#3119PHARMACEUTICAL COMPOSITIONS
#3120Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
#3121INDUCING APOPTOSIS IN QUIESCENT CELLS
#3122Compositions comprising avermectin/azelaic acid compounds useful for treating e.g., rosacea
#3123EFFLUX PUMP INHIBITORS
#3124Composition for modulating inflammation of cardiovascular tissue
#3125Methods and devices for treating conditions associated with autonomic dysfunction
#3126Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
#3127Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria
#3128Combination therapy and methods for treatment and prevention of hyperproliferative diseases
#3129STING (STIMULATOR OF INTERFERON GENES), A REGULATOR OF INNATE IMMUNE RESPONSES
#3130Cyclodextrin-based polymers for therapeutics delivery
#3131Small-molecule inhibitors of Dengue and West Nile virus proteases
#3132Dermatological compositions comprising avermectin nanocapsules
#3133Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
#3134ANTI-INFLAMMATORY COMPOSITIONS FOR TREATING BRAIN INFLAMMATION
#3135extract
#3136Compounds and compositions for treating infection
#3137Crystalline forms of a macrolide, and uses therefor
#3138Modified saponins for the treatment of fungal infections
#3139Glycoside derivatives and uses thereof
#3140Molecular genetic approach to treatment and diagnosis of alcohol and drug dependence
#3141Identification of free-B-ring flavonoids as potent COX-2 inhibitors
#31427-hydroxy chromones as potent antioxidants
#3143CYTOTOXIC THERAPY BY PROTON FLUX MODULATION
#3144Antiprotozoal compound derived from coelenterata
#3145COMBINATION COMPOSITION, COMPRISING AS ACTIVE INGREDIENTS L-CARNITlNE OR PROPIONYL L-CARNITlNE, FOR THE PREVENTION OR TREATMENT OF CHRONIC VENOUS INSUFFICIENCY
#3146Induction of differential stress resistance and uses thereof
#3147Sustained-release formulations of topiramate
#3148Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
#3149Dietary supplement composition of citrus derivatives
#3150PHARMACEUTICAL COMPOSITIONS FOR COMBATING THROMBOTIC DISEASES AND THEIR PREPARATION AND USES
#3151SYNERGISTIC ANTIBIOTIC COMBINATIONS AND DERIVATIVES
#3152COMPOSITIONS FOR TREATMENT OF CHEMORESISTANT AND/OR POTENTIALLY CHEMORESISTANT LEUKAEMIAS
#3153Dynamic inhibitors of heat shock protein 90
#3154Compounds and methods for treating bacterial infections
#3155Bioactive agent delivery particles
#3156Pharmaceutical composition for preventing and treating inflammatory diseases containing an ethyl acetate fraction of dried extract of as an active ingredient, and method for producing the fraction
#3157Bifunctional metnase/intnase inhibitors and related compositions and methods of treatment of cancer
#3158Synergistic combinations of polyene fungicides and non-ribosomal peptides and related methods of use
#3159Cyclodextrin-based polymers for therapeutics delivery
#3160Targeting microRNAs for the treatment of liver cancer
#3161Method for treatment of malaria
#3162Treatment of infections with alpha thymosin peptides
#3163NOVEL COCHLEATE FORMULATIONS
#3164Cyclodextrin-based polymers for therapeutics delivery
#3165Transmucosal administration of drug compositions for treating and preventing disorders in animals
#3166Cyclodextrin-based polymers for therapeutics delivery
#3167COMPOSITIONS AND METHODS OF DELIVERY OF PHARMACOLOGICAL AGENTS
#3168METHODS AND COMPOSITIONS FOR THE TREATMENT OF OBESITY, INSULIN RELATED DISEASES AND HYPERCHOLESTEROLEMIA
#3169PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#3170Composition and method thereof
#3171Cochleate compositions directed against expression of proteins
#3172FLAVANONES-CONTAINING FOOD COMPOSITIONS
#3173Warmi®, natural alternative for the treatment of menopause
#3174PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF METABOLIC DISORDERS
#3175Micelle encapsulation of therapeutic agents
#3176METHODS FOR TREATING OR PREVENTING ALCOHOL-RELATED DISORDERS OR CRAVING-RELATED DISORDERS
#3177Method for treating hematopoietic neoplasms
#3178Stabilized formulation for oral administration of therapeutic agents and related methods
#3179CDK5 Inhibitors and Therapeutic Uses Thereof
#3180Use of albiflorin for anti-depression
#3181USE OF COMPOUNDS WITH SGLT-1/SGLT-2 INHIBITOR ACTIVITY FOR PRODUCING MEDICAMENTS FOR TREATMENT OF BONE DISEASE
#3182HDAC 6 inhibitor-based methods for treating cancer
#3183Compositions and methods for reducing or preventing obesity
#3184Pomegranate fruit polyphenol composition and methods of use and manufacture thereof
#3185Anti-neoplastic compositions comprising extracts of black cohosh
#3186Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
#3187Topical application of ivermectin for the treatment of dermatological conditions/afflictions
#3188PACKAGE AND METHOD OF MARKETING
#3189CATECHINS FOR THE TREATMENT OF AMYLOIDOSIS
#3190Methods for internally controlling or treating equine bot larvae
#3191ANTI-DIABETIC EXTRACT OF HONEYBUSH
#3192Synthesis and identification of novel RSK-specific inhibitors
#3193FLAVANONES-CONTAINING FOOD COMPOSITIONS
#3194METHODS OF REDUCING THE PROLIFERATION AND VIABLILITY OF MICROBIAL AGENTS
#3195Methods for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with proteasome inhibitor
#3196Method for inhibiting activation of macrophages
#3197Methods for treating amyloidosis using 4-(amino)-2-(2,6-Dioxo(3-piperidyl))- isoindoline-1,3-dione
#3198Formulations and methods for treating rhinosinusitis
#3199FGFR1 extracellular domain combination therapies for lung cancer
#3200SAFENER DRUG COMBINATIONS FOR USE WITH NMDA ANTAGONIST DRUGS
#3201LOW CELL TOXICITY ANTIBIOTIC HYGROMYCIN B
#3202PALMARUMYCIN BASED INHIBITORS OF THIOREDOXIN AND METHODS OF USING SAME
#3203Use of Synergistic Combinations of an Avermectin and an Antineoplastic Compounds for the Treatment of Hematological Malignancies
#3204ANTI-NEOPLASTIC COMPOSITIONS COMPRISING EXTRACTS OF BLACK COHOSH
#3205CLARITHROMYCIN EXTENDED-RELEASE TABLET
#3206EPIDITHIODIOXOPIPRAZINES AND USES THEREOF IN TREATING CANCER
#3207Avermectins and milbemycins for the treatment, prevention or amelioration of flavivirus infections
#3208ANTI-NEOPLASTIC COMPOSITIONS COMPRISING EXTRACTS OF BLACK COHOSH
#3209Anti-fungal composition
#3210CEPHALOTAXINE ALKALOID COMPOSITIONS AND USES THEREOF
#3211Treatment of cardiovascular disease and thrombosis
#3212Compositions and methods of improving the tolerability of daunorubicin when given as orotate salt
#3213Isoflavone compositions for reducing accumulation of body fat in male mammals, and methods for their use
#3214Therapy for enteric infections
#3215Treatment of pulmonary hypertension with carbonic anhydrase inhibitors
#3216METHOD AND FORMULATION FOR THE CONTROL OF PARASITES
#3217Animal treatments
#3218PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#3219Use of spinosyns and spinosyn compositions against herpesviridae viral infections
#3220Nanolipidic particles
#3221Composition for prophylaxis or treatment of urinary system infection and method thereof
#3222Pharmaceutical composition comprising an extract of pseudolysimachion longifolium and the catalpol derivatives isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity
#3223Compositions and its use in treating obesity or inducing weight loss
#3224Cyclodextrin-based polymers for therapeutics delivery
#3225Glycoside derivatives and uses thereof
#3226Probiotic, lactic acid-producing bacteria
#3227Assessment and modulation of cerebrospinal fluid for head pain
#3228Biodegradable drug delivery compositions
#3229Compositions and Methods for Selectively Activating Human Sirtuins
#3230Methods for treating malaria, tuberculosis and MAC diseases
#3231Treatment of cancers with A-8R peptide
#3232Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof
#3233Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders
#3234Particulate hyaluronic acid/flavonoid suspensions for cellular delivery of bioactive agents
#3235N-ALKYL LACTAM ETHERS, AND COMPOSITIONS AND USES THEREOF
#3236Core 2 GlcNAc-T inhibitors
#3237Process for manufacturing chewable dosage forms for drug delivery and products thereof
#3238NUTRITIONAL SUPPLEMENT
#3239Application of Antimicrobial and Glycemic Control Activities of Lo Han Kuo Fruit (Siraitia grosvenorii)
#3240Etoposide and doxorubicin conjugates for drug delivery
#3241Method of treating neurological conditions with extract of species or species
#3242COMPOSITIONS AND METHODS FOR ONCE-DAILY ADMINISTRATION OF A TRILAYER OSMOTIC TABLET
#3243Method of manufacture of liposome composition
#3244Compositions Comprising Amphotericin B
#3245Aqueous drug delivery system
#3246Cardiac glycoside analogs in combination with emodin for cancer therapy
#3247Method of lowering glycemic index of foods
#3248Alginate oligomers for use in overcoming multidrug resistance in bacteria
#3249PHARMACEUTICAL AND NUTRACEUTICAL COMPOSITIONS FOR TREATING RESPIRATORY DISEASE AND ASSOCIATED PHLEGM
#3250Treatment of Acinetobacter with alginate oligomers and antibiotics
#3251Method for using ulipristal acetate with cytochrome isozyme modulators
#3252Anti-microbial compositions
#3253Methods for renal denervation
#3254Compositions and methods for increasing compliance with therapies using aldehyde dehydrogenase inhibitors and treating alcoholism
#3255Mangiferin-berberine salt, manufacturing method and use thereof
#3256PHARMACEUTICAL COMPOSITIONS FOR TREATING METASTASIS
#3257Chroman derivatives
#3258Anti-biofilm compositions and methods for using
#3259STIMULATION OF NEUROREGENERATION BY FLAVONOID GLYCOSIDES
#3260AVERMECTIN/METRONIDAZOLE COMPOSITIONS FOR TREATING AFFLICTIONS OF THE SKIN, E.G., ROSACEA
#3261Pharmaceutical anti-infective composition for inhalation
#3262Agent for inhibiting peritoneal membrane thickening
#3263READILY WATER-SOLUBLE ISOQUERCITRIN COMPOSITION
#3264Pharmaceutical composition and use of the pharmaceutical composition for the treatment, prophylaxis or prevention of neoplastic diseases in humans and animals
#3265Controlled release systems of pluribioactive antifungal drugs and applications thereof
#3266Topical application of ivermectin for the treatment of dermatological conditions/afflictions
#3267Methods for treating heart failure by inhibiting the mitochondrial sodium-calcium exchanger (mNCE)
#3268MODIFIED GREEN TEA POLYPHENOL FORMULATIONS
#3269Composition for use in gene therapy
#3270ALKYLSACCHARIDE COMPOSITIONS WITH NUTRACEUTICALS
#3271Zero Calorie Polyphenol Aqueous Dispersions
#3272SYSTEM AND METHODS FOR PHARMACY MANAGEMENT OF DRUGS
#3273Cyclodextrin-based polymers for therapeutics delivery
#3274METHOD OF ACCELERATING MUSCLE GROWTH, DECREASING FAT DEPOSITS AND IMPROVING FEED EFFICIENCY IN LIVESTOCK ANIMALS
#3275Benzoyl Peroxide Composition, Methods for Making Same, and Pharmaceutical or Cosmetic Formulations Comprising Same, and Uses Thereof
#3276DICHLORACETATE IN COMBINATION WITH CLINICALLY HIGH LEVELS OF CARDIOPROTECTIVE OR HEMODYNAMIC DRUGS
#3277PRENYLFLAVONOID FORMULATIONS
#3278Pharmaceutical Composition for Treating Cancers
#3279Methods for treating scars and aging skin
#3280Aesthetic treatment of scars and aging skin
#3281Administration of avermectin/milbemycin compounds for the treatment of ophthalmic pathologies
#3282Diagnosis and treatment of drug-resistant Ewing'S sarcoma
#3283MOLECULAR ACTIVATORS OF THE WNT/BETA-CATENIN PATHWAY
#3284COUMARIN COMPOUNDS AND THEIR USE FOR TREATING VIRAL INFECTION
#3285CONNEXIN ENHANCES CHEMOTHERAPY-INCLUDED APOPTOSIS IN HUMAN CANCER CELLS INHIBITING TUMOR CELL PROLIFERATION
#3286Antibiotic macrocycle compounds and methods of manufacture and use thereof
#3287METHODS OF TREATING MULTIPLE MYELOMA USING MELPHALAN, PREDNISONE AND LENALIDOMIDE
#3288FULVIC ACID IN COMBINATION WITH FLUCONAZOLE OR AMPHOTERICIN B FOR THE TREATMENT OF FUNGAL INFECTIONS
#3289Use of nifuratel to treat infections caused by species
#3290Combination of compounds for treating or preventing skin diseases
#3291Isoxazoline derivatives as antiparasitic agents
#3292Once a day amoxicillin product comprising immediate and delayed release dosage forms
#3293TREATMENT OF NEUROTROPHIC FACTOR MEDIATED DISORDERS
#3294Compositions for treating obesity and insulin resistance disorders
#3295Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle
#3296USING HEAT SHOCK PROTEINS TO IMPROVE THE THERAPEUTIC BENEFIT OF A NON-VACCINE TREATMENT MODALITY
#3297Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
#3298Seroma Control for Surgical Patients
#3299Formulation for treating fungal infection
#3300Anti-penicillin resistant pneumococci agent and novel 16-membered macrolide derivative